Targeting stroma and tumor, silencing galectin 1 treats orthotopic mouse hepatocellular carcinoma is a research paper published in Acta Pharmaceutica Sinica B (2023). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA222490
National Institutes of Health
Grant: R50CA243787
National Institutes of Health
Grant: T32 CA108459–15
National Institutes of Health
Grant: 5R50CA243787-02
Gut microbiota-derived signaling in liver carcinogenesis and cancer treatment
National Institutes of Health
Grant: 5T32CA108459-14
Training Program in Oncogenic Signals and Chromosome Biology
National Institutes of Health
Grant: 1R01CA222490-01
Liver Cancer Therapy by MiR-22 and Its Inducers
Fields of Study
Keywords
Sustainable Development Goals